Inhaled nitric oxide developer Beyond Air announced that pulmonologist Andrew Colin has been appointed as the company's Chief Medical Officer, effective December 1, 2021. Colin, who was most recently Chief of the Division of Pediatric Pulmonology at the University of Miami's Miller School of Medicine and Director of the university's Cystic Fibrosis Center, has … [Read more...] about Andrew Colin joins Beyond Air as Chief Medical Officer
People
Philip Canner joins Cambridge Healthcare Innovations as CEO
Device developer Cambridge Healthcare Innovations (CHI) has announced the appointment of former AuroScience Head of Device Development Philip Canner as CEO. In addition to AuroScience, an Aurobindo subsidiary that develops generic inhaled drugs, Canner's OINDP development experience also includes a stint at Team Consulting. Earlier this year, CHI partnered with … [Read more...] about Philip Canner joins Cambridge Healthcare Innovations as CEO
Merxin partners with the University of Hertfordshire for research on SMIs
Generic inhalation device developer Merxin has announced a three-year partnership with the University of Hertfordshire to further research on "the generation of fine mist and particle aerosols from formulations for deep lung delivery." Merxin will sponsor doctoral work by UH PhD student Aurélien Martin under the supervision of Professor Darragh Murnane that will … [Read more...] about Merxin partners with the University of Hertfordshire for research on SMIs
PARI Pharma names Stefan Seemann as its new President
PARI Pharma has named Stefan Seemann as its new President, effective July 1, 2021. Seeman will take over from Martin Knoch, who is retiring after more than 30 years at PARI Pharma, where he oversaw development of the company's eFlow nebulizer technology. Seeman, who joined PARI Pharma in 2000 after several years at Boehringer Inhgelheim, was most recently VP for eFlow … [Read more...] about PARI Pharma names Stefan Seemann as its new President
Valeo launches Enerzair Breezhaler and Atectura Breezhaler in Canada
Valeo Pharma has announced the launch of the Enerzair Breezhaler indacaterol / glycopyrronium / mometasone furoate and Atectura Breezhaler indacaterol / mometasone furoate DPIs in Canada. The company acquired Canadian rights to the two Novartis dry powder inhalers in March 2021. Enerzair (QVM149) and Atectura (QMF149) are also approved in Europe and in … [Read more...] about Valeo launches Enerzair Breezhaler and Atectura Breezhaler in Canada
Proveris Scientific hires Prateek Nath as research scientist
Proveris Scientific, a specialist in aerosol drug delivery testing, announced that it has hired engineer Prateek Nath to "to design and build a wide variety of research-grade prototypes and run experiments on these prototypes to generate proof statements for scientific hypotheses related to aerosol science, human physiology, and drug delivery." Nath was most … [Read more...] about Proveris Scientific hires Prateek Nath as research scientist
Proveris hires Maria L. Smith to head up business development for Proveris Laboratories
Aerosol testing specialist Proveris Scientific has named Maria L. Smith as Director, Application and Business Development for Proveris Laboratories. Smith has extensive experience in OINDP spray characterization, first at DPT Laboratories and then at Renaissance Lakewood. In addition to business development for the lab, she is expected to "serve as a liaison to … [Read more...] about Proveris hires Maria L. Smith to head up business development for Proveris Laboratories
Adherium appoints new CEO, submits 510(k) application for next generation Hailie sensor after rejecting takeover bid
Inhaler monitoring company Adherium has submitted a 510(k) application for a new Hailie sensor designed to work with the Symbicort MDI the company announced. The company recently rejected a takeover bid from another Australian asthma monitoring company called Respiri and then named a new CEO, its sixth chief executive since 2017, saying that it "must continue … [Read more...] about Adherium appoints new CEO, submits 510(k) application for next generation Hailie sensor after rejecting takeover bid
Inhalation Sciences forms new scientific advisory board
Aerosol research instrument company Inhalation Sciences (ISAB) has announced the formation of a new scientific advisory board, which will begin meeting on June 1, 2021 to discuss how the company's PreciseInhale laboratory aerosol dosing system can be used once it has been validated for clinical use. Members of the new scientific advisory board include Carsten Ehrhardt … [Read more...] about Inhalation Sciences forms new scientific advisory board
Aerovate names Timothy Noyes as CEO
Aerovate Therapeutics has announced that former Proteon Therapeutics President and CEO Timothy Noyes has been named CEO and elected to the company's board of directors. Noyes was most recently CEO of Arcuate Therapeutics, and he previously served in executive roles at Genzyme and GelTex Pharmaceuticals after beginning his career at Merck. Aerovate's lead candidate is … [Read more...] about Aerovate names Timothy Noyes as CEO